Navigation Links
Medpace Strengthens Presence in Central Europe

CINCINNATI and PRAGUE, Czech Republic, Aug. 21 /PRNewswire/ -- Medpace, Inc., a leading global full-service contract research organization, today announced it has completed the acquisition of Monax s.r.o., a regional contract research organization (CRO) headquartered in Prague, Czech Republic. This move strengthens the Medpace presence in Central Europe and expands its capacity to provide full service clinical research management within the Czech Republic and Slovakia. Petr Potuznik, MD, the founder of Monax, will continue to lead Medpace clinical operations for the region.

"We are excited to welcome the Monax team to the Medpace family," said August Troendle, MD, Medpace Chief Executive Officer. "The expertise of Dr. Petr Potuznik and his highly trained team fit perfectly within our strategic global expansion plan."

"We have worked closely with Medpace in the past and found that our companies shared a high level of expertise and commitment to quality," said Potuznik. "Becoming part of the Medpace group allows the Monax team to grow and expand our presence and capabilities throughout the region."

About Medpace

Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.

Through specialized regulatory expertise and therapeutically focused clinical operations, Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development - from program planning and execution to product approval.

With more than 500 employees and clinical trial experience in nearly 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide within the core therapeutic areas of cardiology, metabolism, and oncology.

The Medpace group of companies also includes

Imagepace - a centralized imaging laboratory with expertise in cIMT

Medpace Reference Laboratory - a centralized lab with therapeutically specialized testing

Medpace Clinical Pharmacology - a Phase I/IIa unit scheduled to open in Q1, 2008.

Contact: Stephanie Lusk 513-579-9911 x1102

SOURCE Medpace, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BIO 2007: Wisconsin makes its presence felt
2. TDS trades markets to gain Duluth presence
3. West Coast VC Establishes Midwest Presence in Madison
4. Sony Bets Heavy on Wisconsin Digital Entertainment Presence
5. Madison start-up Central Signal gets $350K grant
6. Will wireless Internet bypass the central city?
7. Norlight to expand fiber network into central Illinois
8. Centralization mania takes over
9. Meterologix Media Division acquired by Madison-based Weather Central
10. Weather Central launches second satellite
11. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
Breaking Biology News(10 mins):